Eledon Pharmaceuticals, Inc.

NASDAQ:ELDN

Biotechnology

Healthcare
$2.03 +2.84%

+$0.11 today

Market cap
$171.45M
Beta
0.97
P/E (TTM)
-5.5
EPS (TTM)
-$0.70
52W Low $1.35High $4.60

Volume 1.12M

Average 1.37M

Balance Sheet

Inspect the capital base behind the business.

Assets

$169.01M

FY 2025 · Annual

-4.7% YoY

Liabilities

$87.92M

FY 2025 · Annual

+48.4% YoY

Equity

$81.08M

FY 2025 · Annual

-31.4% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents84.83M56.41M4.61M20.55M22.81M
Short-term Investments0046.49M119.63M110.53M
Net Receivables0000514K
Inventory00000
Other Current Assets34K28K90K729K11K
Total Current Assets88.35M59.52M56.13M143.73M135.69M
Property, Plant & Equipment (Net)768K739K365K926K613K
Goodwill48.65M0000
Intangible Assets32.39M32.39M32.39M32.39M32.39M
Long-term Investments00000
Tax Assets00000
Other Non-current Assets400K150K186K363K322K
Total Non-current Assets82.2M33.28M32.94M33.68M33.32M
Total Assets170.55M92.79M89.07M177.41M169.01M
Account Payables1.81M2.2M967K5.83M3.63M
Short-term Debt00000
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities1.52M1.91M2M1.6M4.18M
Total Current Liabilities4.4M6.48M3.9M11.58M18.34M
Long-term Debt00000
Deferred Tax Liabilities1.75M01.75M2.18M2.19M
Deferred Revenue (Non-current)00000
Other Non-current Liabilities01.75M76.21M44.87M67.11M
Total Non-current Liabilities2.15M2.14M77.96M47.69M69.58M
Total Liabilities6.55M8.61M81.86M59.27M87.92M
Common Stock14K14K24K60K75K
Retained Earnings(114.9M)(202.87M)(319.4M)(355.59M)(401.2M)
Accumulated OCI00026K24K
Other Stockholders Equity0(0)000
Minority Interest00000
Total Equity164M84.18M7.21M118.14M81.09M
Total Debt769K746K383K954K641K
Net Debt(84.06M)(55.66M)(4.23M)(19.6M)(22.17M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$6.2M
Short-term Investments$104.9M
Receivables$583.0K
Other Current$1.9M
Total Current Assets$113.6M
PP&E (Net)$530.0K
Intangible Assets$32.4M
Other Non-current$177.0K
Total Non-current Assets$33.1M
Total Assets$146.7M

Analysis

Selected assets total $146.7M for Latest. The largest visible component is Short-term Investments at $104.9M, about 71.5% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportNov 12, 2026
10-QQuarterly reportNov 12, 2026
SC 13G/ASC 13G/A filingOct 30, 2026
S-8S-8 filingSep 4, 2026
10-QQuarterly reportAug 13, 2026

How much cash does ELDN have?

Eledon Pharmaceuticals, Inc. (ELDN) reported $22.81M in cash and equivalents in fiscal 2025.

How much debt does ELDN carry?

Eledon Pharmaceuticals, Inc. (ELDN) reported $641,000.00 of total debt, with net debt of -$22.17M.